MedTrace Logo

Dilated Cardiomyopathy-Cardiac Magnetic Resonance (DCM-CMR) Ancillary Study

NCT04638621 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 650

Last updated 2026-04-21

No results posted yet for this study

Summary

The Dilated Cardiomyopathy-Cardiac Magnetic Resonance (DCM-CMR) Study is an ancillary study from the parent study, DCM Precision Medicine Study. The rationale for the DCM-CMR study is to leverage cardiac magnetic resonance (CMR) imaging to detect earliest findings of DCM in the at-risk family members enrolled into the parent study.

Conditions

  • Dilated Cardiomyopathy

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • Ohio State University

    lead OTHER

Principal Investigators

  • Ray Hershberger, MD · Ohio State University

  • Karolina Zareba, MD · Ohio State University

  • Daniel Kinnamon, PhD · Ohio State University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-04-01
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04638621 on ClinicalTrials.gov